Objective: Retrospective study of surgical pathology experience on car
diac and pericardial tumors at the University of Padua in the era of i
mmunohistochemistry and endomyocardial biopsy. Methods: In the period
1970-1995, we studied 125 bioptic primary neoplasms: specimens were ob
tained from surgical resection in 116 cases, heart transplantation in
3, pericardiectomy in 3, endomyocardial biopsy in 2 and thoracoscopic
biopsy in 1. Tumor histotype was established by light microscopy and m
ore recently by immuno-histochemistry. using a large panel of antibodi
es, through avidin-biotin peroxidase method, against factor VIII-relat
ed antigen, ulex-europaeus, desmin, myoglobin, muscle-specific actin,
smooth muscle-specific actin, vimentin, cytokeratins, leukocytic commo
n antigen, neurofilaments and S100-protein. Results: One hundred and t
hirteen were benign neoplasms: myxoma was the most frequent (87 cases)
followed by pericardial cyst (8), endocardial papilloma (5), fibroma
(3), rhabdomyoma (3), hematic cyst (2), teratoma (2), hemangioma (1),
celothelioma (1) and lipoma (1). Malignancy was diagnosed in 12 cases.
and consisted of pericardial mesothelioma (3), myxosarcoma (3), angio
sarcoma (2), fibrosarcoma (2) and leiomyosarcoma (2); 4 of them were i
ntracavitary atrial masses and were supposed to be atrial myxoma on th
e clinical ground. Differential diagnosis included endocardial thrombo
sis (10), metastasis of concealed extracardiac tumors (5), echinococco
sis (3), and Loeffler's fibroplastic endocarditis (3). In 4 cases, car
diac mass histotype was defined without thoracotomy, through endomyoca
rdial (3) and thoracoscopic (I) biopsy. Conclusions: A large spectrum
of cardiac tumors is observed in the surgical pathology practice. Alth
ough the diagnosis of cardiac masses is easily attainable by routine i
maging techniques, differential diagnosis between primary and secondar
y tumors, malignant and benign forms, and non neoplastic masses, is ac
hievable only by a thorough microscopic study of surgical resections.
The role of the cardiac pathologist is becoming crucial as in other fi
elds of oncology. (C) 1997 Elsevier Science B.V.